Metabolic activity of gut bacteria can either promote or inhibit function of CAR T cells in cancer therapy
Immunotherapies, especially CAR T-cell therapy, have fundamentally changed cancer treatment in recent years, particularly for certain forms of leukemia and lymphoma. Yet not all tumors respond equally well, and the reasons for this remain incompletely understood. A new multicenter study by the Leibniz Institute for Immunotherapy collaboration group, Innate Immune Sensing in Cancer and…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Resistance gene helps C. difficile spores survive hospital-grade disinfectants
United Kingdom
-
Blueberries can modify the gut microbiome in older adults with mild depression
United Kingdom
-
Exercise as medicine—how exercise protects joints in aging-related osteoarthritis
United Kingdom
-
Early complications common in older kidney transplant recipients
United Kingdom
-
Tiny blood clots help guide blood flow as placenta develops, mouse study finds
United Kingdom
-
1997 to 2022 saw an increase in pediatric hospitalizations with acute kidney injury
United Kingdom
-
Emergency room intervention pairs smartphone and telehealth counseling to reduce risky firearm behavior
United Kingdom
-
Microplastics clog liver immune cells, driving fat buildup in mice
United Kingdom